Back
Endava PLC Vs. Akero Therapeutics Industry Stock Comparison
Sell
37
DAVA
Endava PLC
Last Price:
$14.95
Seasonality Move:
9.69%
Buy
53
AKRO
Akero Therapeutics
Last Price:
$56.32
Seasonality Move:
34.97%
Sell
37
Endava PLC (DAVA)
is a Sell
Is Endava PLC a Buy, Sell or Hold?
-
The current Endava PLC [DAVA] share price is $14.70. The Score for DAVA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
DAVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $55.04. The Score for AKRO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DAVA Stock Price Chart
What is Endava PLC's stock price today?
-
The Endava PLC share price today is $14.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAVA is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $55.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
DAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 41.96 | Sell |
Chaikin Money Flow: | -181406 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.46 - 16.14) | Sell |
Bollinger Bands (100): | (14.86 - 26.72) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.47 | Buy |
Relative Strength Index (14 RSI): | 64.86 | Buy |
Chaikin Money Flow: | 663430 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.63 - 55.25) | Buy |
Bollinger Bands (100): | (40.1 - 52.3) | Buy |
DAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.75 | Sell |
20-day SMA: | 15.44 | Sell |
50-day SMA: | 16.7 | Sell |
200-day SMA: | 24.63 | Sell |
8-day EMA: | 14.8 | Sell |
20-day EMA: | 15.36 | Sell |
50-day EMA: | 15.13 | Sell |
200-day EMA: | 8.33 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.86 | Buy |
20-day SMA: | 53.06 | Buy |
50-day SMA: | 46.33 | Buy |
200-day SMA: | 37.77 | Buy |
8-day EMA: | 54.4 | Buy |
20-day EMA: | 52.52 | Buy |
50-day EMA: | 48.38 | Buy |
200-day EMA: | 39.65 | Buy |
Endava PLC Earnings Growth & DAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $0.01 per share, and an increase next year of $0.14 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.72 per share.
Endava PLC Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |